After the addition of CB, the CP was marginally enhanced in C− (P=0.028) and C+ (non-significant (NS), P=0.115), but significantly increased by comparison in T2DM− (P<0.001) and in T2DM+ (P=0.003; Figure 2; panel C), with that of the T2DM− being greater than in T2DM+ group. The gene discussed is CP; the disease is type 2 diabetes mellitus.